Skip to main content
The decision to move the levonorgestrel emergency contraceptive pill Plan B (Barr Laboratories, Pomona, NY) to over-the-counter status has been delayed by the Food and Drug Administration.

Bulletin: FDA delays decision on Plan B

April 1, 2004

The decision to move the levonorgestrel emergency contraceptive pill Plan B (Barr Laboratories, Pomona, NY) to over-the-counter status has been delayed by the Food and Drug Administration.

Subscribe Now for Access

You have reached your article limit for the month. We hope you found our articles both enjoyable and insightful. For information on new subscriptions, product trials, alternative billing arrangements or group and site discounts please call 800-688-2421. We look forward to having you as a long-term member of the Relias Media community.

If you already have a subscription to this publication, please log in to view the full article. If not, consider one of the subscription options below.

Contraceptive Technology Update: Online - $449

All Access Subscription: Online - $349

Our All Access Subscription provides unlimited access to our entire publication and article library. It includes over 1,000 articles published annually, access to 500+ CME/CE credit hours per year, and access to 24 yearly publications.

Learn More
Go Back